A case of lupus-like syndrome in a patient receiving adalimumab and a brief review of the literature on drug-induced lupus erythematosus.
J Clin Pharm Ther
; 42(3): 363-366, 2017 Jun.
Article
en En
| MEDLINE
| ID: mdl-28191663
ABSTRACT
WHAT IS KNOWN AND OBJECTIVE:
Drug-induced lupus erythematosus occurs with some drugs and resolves with their withdrawal. Anti-TNF therapies have been found to be associated with a lupus-like syndrome, which is clinically distinct from classical drug-induced as well as idiopathic lupus erythematosus. CASE DESCRIPTION We describe a case of a patient with severe psoriasis, who developed muscle pain with paraesthesia accompanied by ANA titres elevation with adalimumab treatment. The condition resolved after adalimumab cessation, and the patient was started on ustekinumab with good results. WHAT IS NEW ANDCONCLUSION:
Ustekinumab might be a useful treatment option for patients with a history of TNF-induced lupus-like syndrome.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Adalimumab
/
Lupus Eritematoso Sistémico
/
Antiinflamatorios
Límite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
J Clin Pharm Ther
Asunto de la revista:
FARMACIA
/
TERAPEUTICA
Año:
2017
Tipo del documento:
Article
País de afiliación:
República Checa